Does CABERGOLINE Cause Ovarian hyperstimulation syndrome? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Ovarian hyperstimulation syndrome have been filed in association with CABERGOLINE (Cabergoline). This represents 1.5% of all adverse event reports for CABERGOLINE.
32
Reports of Ovarian hyperstimulation syndrome with CABERGOLINE
1.5%
of all CABERGOLINE reports
3
Deaths
25
Hospitalizations
How Dangerous Is Ovarian hyperstimulation syndrome From CABERGOLINE?
Of the 32 reports, 3 (9.4%) resulted in death, 25 (78.1%) required hospitalization.
Is Ovarian hyperstimulation syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABERGOLINE. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does CABERGOLINE Cause?
Drug ineffective (249)
Headache (142)
Off label use (129)
Nausea (103)
Maternal exposure during pregnancy (100)
Dizziness (94)
Cerebrospinal fluid leakage (78)
Fatigue (71)
Malaise (64)
Condition aggravated (61)
What Other Drugs Cause Ovarian hyperstimulation syndrome?
CHORIOGONADOTROPIN ALFA (1,016)
FOLLITROPIN (718)
GANIRELIX (672)
TRIPTORELIN (356)
PROGESTERONE (293)
MENOTROPINS (238)
LUTROPIN ALFA (194)
GONADOTROPHIN, CHORIONIC (173)
FOLLITROPIN BETA (163)
FOLLITROPIN ALFA (138)
Which CABERGOLINE Alternatives Have Lower Ovarian hyperstimulation syndrome Risk?
CABERGOLINE vs CABOTEGRAVIR
CABERGOLINE vs CABOTEGRAVIR\RILPIVIRINE
CABERGOLINE vs CABOZANTINIB
CABERGOLINE vs CABOZANTINIB S-MALATE
CABERGOLINE vs CAFFEINE